Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4596738 | 0.71 | CA2 (0.32) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL11880857 | 0.69 | CA2 (0.36) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL2917187 | 0.68 | CA2 (0.34) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL5646321 | 0.67 | CA2 (0.37) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL11876678 | 0.66 | CA2 (0.30) | CA2 | |
| SCHEMBL5645948 | 0.66 | CA2 (0.36) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL2229712 | 0.66 | CA2 (0.32) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL10523972 | 0.66 | CA2 (0.44) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL30538382 | 0.66 | CA2 (0.44) | CA2ALDH1A1TSHRCYP3A4ATM | |
| SCHEMBL25543730 | 0.65 | ALDH1A1 (0.42) | CA2ALDH1A1TSHRCYP3A4ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6323275-B2 | HAVING A LOWERED ADHESION TO THE SKIN | TOAGOSEI CO., LTD. (JP) | 2001-11-27 | — | — | US | claimed |
| US-12305082-B2 | Curable-type composition, two-component curable-type composition set, and method of producing adhered product | TOAGOSEI CO., LTD. | 2025-05-20 | — | — | US | disclosed |
| US-20230391903-A1 | CURABLE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2023-12-07 | — | — | US | disclosed |
| US-20230002642-A1 | CURABLE COMPOSITION, TWO-LIQUID TYPE CURABLE COMPOSITION SET, AND METHOD FOR MANUFACTURING ADHERED PRODUCT | TOAGOSEI CO., LTD. (JP) | 2023-01-05 | — | — | US | disclosed |
| US-20220380615-A1 | CURABLE COMPOSITION, TWO-LIQUID TYPE CURABLE COMPOSITION SET, AND METHOD FOR MANUFACTURING ADHERED PRODUCT | TOAGOSEI CO., LTD. (JP) | 2022-12-01 | — | — | US | disclosed |
| US-20220325148-A1 | EASILY WATER-DISMANTLABLE ADHESIVE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2022-10-13 | — | — | US | disclosed |
| US-20220298105-A1 | 2-CYANOACRYLATE COMPOUND AND ADHESIVE COMPOSITION | TOAGOSEI CO., LTD. (JP) | 2022-09-22 | — | — | US | disclosed |
| US-20220282135-A1 | CURABLE-TYPE COMPOSITION, TWO-COMPONENT CURABLE-TYPE COMPOSITION SET, AND METHOD OF PRODUCING ADHERED PRODUCT | TOAGOSEI CO., LTD. (JP) | 2022-09-08 | — | — | US | disclosed |
| EP-4011993-A1 | ADHESIVE COMPOSITION WHICH EASILY DISINTEGRATES IN WATER | Toagosei Co., Ltd. (JP) | 2022-06-15 | — | — | EP | disclosed |
| EP-4011863-A1 | 2-CYANOACRYLATE COMPOUND AND ADHESIVE COMPOSITION | Toagosei Co., Ltd. (JP) | 2022-06-15 | — | — | EP | disclosed |
| US-6323275-B2 | HAVING A LOWERED ADHESION TO THE SKIN | TOAGOSEI CO., LTD. (JP) | 2001-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220298105-A1 | 2-CYANOACRYLATE COMPOUND AND ADHESIVE COMPOSITION | ITGA1, COL1A1, ITGB1 | CA2 469/4885ALDH1A1 305/4885TSHR 4636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.